FindTrial
Sign In

Use of immunohistochemistry and direct immunofluorescence in diagnosis of primary cicatricial alopecia

Diagnostic utility of Immunohistochemistry and Direct Immunofluorescence in primary cicatricial alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026308
Enrollment
25
Registered
2020-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Control Intervention1: Nil: Nil

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical and histologically diagnosed primary cicatricial alopecia .

Exclusion criteria

Exclusion criteria: 1.Patients undergoing treatment will be excluded from the study. 2.Cases of secondary cicatricial alopecia such as infection,inflammatory skin disease.

Design outcomes

Primary

MeasureTime frame
To study the pattern and type of immunoreactant deposition in cicatricial alopecia using Direct immunofluorescence and Immunohistochemistry in primary cicatricial alopecia.Timepoint: Single Time—

Secondary

MeasureTime frame
1.To study the histopathologic spectrum of primary cicatricial alopecia. 2.To study the association of pathological findings with direct immunofluorescence and immunohistochemistry results.Timepoint: Single Time—

Countries

India

Contacts

Public ContactYankila Tamang

Maulana Azad Medical College

nitakhurana1@gmail.com9968604289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026